Adicet Bio
ACET
#10696
Rank
S$29.69 M
Marketcap
S$3.17
Share price
-1.60%
Change (1 day)
318.81%
Change (1 year)

Adicet Bio (ACET) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : S$36.14 Million

According to Adicet Bio's latest financial reports the company's total liabilities are S$36.14 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Adicet Bio - Total liabilities on balance sheet (from 2019 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31S$42.55 M-6.85%
2024-12-31S$45.68 M-6.81%
2023-12-31S$49.02 M-4.65%
2022-12-31S$51.41 M6.21%
2021-12-31S$48.41 M-16.85%
2020-12-31S$58.21 M-69.58%
2019-12-31S$0.19 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Novartis
NVS
S$102.63 B 283,848.19%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$149.12 B 412,483.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$113.24 B 313,222.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$41.39 B 114,428.33%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Hawkins
HWKN
S$0.57 B 1,499.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Quaker Houghton
KWR
S$1.89 B 5,146.61%๐Ÿ‡บ๐Ÿ‡ธ USA